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Abstract 
Introduction: Obesity has increased rapidly among children and adolescents during the last 30 years. Paediatric patients with a BMI above 
the 85th centile are more often diagnosed with increased TSH levels than are children with proper body weight. 
Material and methods: The data of 961 overweight and obese children, aged 13 years, recruited in four cities in Poland as part of PoZdro!, 
a two-year prophylactic program, were analysed to observe the relationship between serum TSH and fT4 concentration and carbohydrate 
and lipid metabolism parameters, as well as anthropometric parameters.
Results: TSH concentration in the study group was positively correlated, whereas fT4 concentration was negatively correlated with 
WHR and WHtR values, fasting serum glucose concentrations and one-hour glucose concentration, fasting serum insulin concentrations, 
one-hour and two-hour insulin concentration, ALT serum activity, as well as total cholesterol, LDL cholesterol, and triglyceride serum 
concentrations. An increased risk of metabolic syndrome was diagnosed previously in patients with TSH concentrations > 2.5 mUI/L.
Conclusions: TSH concentration in the upper half of the current reference range (> 2.50 mIU/L) is associated with an increased risk of 
lipid and carbohydrate metabolism disorders and therefore increased chances of developing metabolic syndrome. It seems advisable to 
regularly monitor thyroid function in overweight and obese paediatric patients. (Endokrynol Pol 2019; 70 (2): 172–178)
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Introduction 
During the last 30 years a significant increase in obesity 
among children has been observed [1, 2]. The incidence 
rate of excessive body mass in children and teenagers 
in Poland is 3.4–17.2%, which is comparable to other 
developed countries in the world [3–5]. However, the 
connection between thyroid activity in children and the 
development of metabolic syndrome, insulin resistance, 
or lipid metabolism disorders has not yet been fully 
explained [6–8].
Serum thyroid-stimulating hormone (TSH) and free 
thyroxine (ft4) concentrations in children with excessive 
body mass are constantly fluctuating [9]; therefore, it is 
not entirely clear whether the wide range of TSH refer-
ence values (uniform for the entire population) should 
be modified. Thyroid hormones are primarily respon-
sible for maintaining the body’s energy homeostasis, as 
well as regulating lipid and carbohydrate metabolism 
[10]. A reduced free thyroxine (fT4) concentration seems 
to be connected with insulin resistance increase and 
metabolic syndrome development, which contributes 
to an increase of cardiovascular risk [11, 12].
The study attempted to identify the association of 
serum TSH and fT4 concentrations with carbohydrate 
and lipid metabolism parameters.
Material and methods
The analysis incorporated data for 961 children, including 442 
(46.0%) girls and 519 (54%) boys, overweight or obese, aged 13 years, 
recruited from four cities in Poland (Gdynia, Warsaw, Lublin, and 
Wrocław) in the years 2013–2016 as part of the PoZdro! National 
Program for the Prevention of Diabetes and Civilisation-related 
Diseases (Ogólnopolski Program Profilaktyki Cukrzycy i Chorób 
Cywilizacyjnych PoZdro!). 
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dard deviations (SD), medians, and extreme values (minimum and 
maximum). Statistical characteristics of qualitative variables were 
presented as numeric and percentage distributions. The Mann-
Whitney U test or the Kruskal-Wallis test with post-hoc Dunn’s test 
were used for inter-group comparisons of statistical characteristics 
of the measurable variables. In order to compare inter-group dis-
tributions of qualitative variables, Pearson’s chi-squared test was 
used. The power and direction of the correlation between pairs of 
measurable variables was assessed on the basis of Spearman’s rank 
correlation coefficient values (R).
All parents of the pupils taking part in the PoZdro! Program 
signed informed consent forms. The Ethics Committee from 
Medical University of Gdansk agreed to the investigation (NK-
BBN/301/2014). The reported investigations were carried out in 
accordance with the principles of the Declaration of Helsinki as 
revised in 2000.
Results
Statistical characteristics of the TSH and fT4 concentra-
tions for the entire study group are presented in Table I.
Study subjects included 472 (49.1%) overweight 
children and 489 (50.9%) obese children. There was 
no significant difference between the groups in terms 
of TSH concentration. However, fT4 concentration in 
overweight children was significantly higher than in 
the obese ones (Tab. II). In the entire group there were 
three adolescents with TSH level above 10 µIU/mL 
(11.7 µIU/mL, 13.8 µIU/mL, and 14 µIU/mL, respec-
tively), who were diagnosed with hypothyroidism 
and started L-thyroxine treatment. The data of those 
three patients were not excluded from the study; 
however, further analyses revealed no statistical dif-
ferences whether these data were or were not taken 
into consideration.
Values of lipid profile were as following (mean and 
standard deviation) — total cholesterol 155 ± 28 mg%; 
LDL-cholesterol 92 ± 49 mg%; triglycerides 86± 24 mg% 
and HDL-cholesterol 50 ± 11 mg%.
During visits the patients had their anthropometric parameters 
measured: height, body mass, waist and hip circumference, and 
triplicate measurements of arterial blood pressure.
Height was measured using a stadiometer under standard condi-
tions, with patients in the Frankfurt position, without shoes. Body 
mass was measured using an electronic scale with bioimpendance, 
with patients in their underwear and without shoes. The children’s 
waist and hip circumference measurements were conducted using 
anthropometric tape, with patients in a standing position. Waist 
circumference measurements were taken at the mid-distance be-
tween the costal arches and iliac wings, while hip circumference 
measurements were taken at the widest point below the iliac wings. 
BMI was calculated based on the above measurements. Being obese 
or overweight was defined based on age- and gender-specific 
BMI centile grids, developed as part of the OLAF project [13, 14]. 
Overweight was defined as ranging from the 85th to the 95th centile, 
whereas obesity as being at or above the 95th centile for the specific 
gender and age group [13].
The following laboratory tests were also conducted for all patients: 
peripheral blood cell count, TSH and fT4 concentration, oral glu-
cose tolerance test with assessment of glucose and insulin levels 
(fasting, one-hour and two-hour), ALT activity, lipid panel (total 
cholesterol, LDL cholesterol, HDL cholesterol, triglycerides), uric 
acid, and creatinine. Whole blood samples collected from the pa-
tients were used for the complete blood count, while serum was 
used for other tests. Blood samples were collected after a minimum 
of eight hours of fasting.
As the normal range for all measurements we used the cut-offs for 
13-year-olds used by Synevo Laboratories, where all the measure-
ments were performed. The normal range of TSH used for 13 years 
old was 0.27–4.2 µIU/mL and for fT4 levels 12–22 pmol/l. Patients 
with TSH level above 10 mU/l and fT4 levels below normal range 
were diagnosed with hypothyroiditis and started the treatment 
with L-thyroxine. 
Metabolic syndrome was diagnosed based on IDF (International 
Diabetes Federation) criteria from 2007. (14) Children with waist 
circumference above 90th percentile and two or more accompanying 
laboratory founds (triglycerides > 150 mg/dL; HDL < 40 mg/dL; 
glucose level > 100 mg/dL; blood pressure >130/85 mm Hg) were 
diagnosed with metabolic syndrome.
All calculations were conducted using the Statistica 10 software 
(StatSoft, United States of America), with the assumed statistical 
significance threshold of p ≤ 0.05.  
Normality of distribution for the analysed quantitative variables 
was assessed using the Shapiro-Wilk test. Statistical characteristics 
of quantitative variables were presented as arithmetic means, stan-
Table I. Statistical characteristics of the thyroid-stimulating hormone (TSH) and free thyroxine (fT4) concentrations 
for the entire study group
Variable n Mean Median Minimum Maximum SD
TSH [mU/L] 961 2.49 2.24 0.47 14.03 1.32
fT4 [pmol/L] 961 15.13 15.05 8.52 44.18 2.36
SD — standard deviation
Table II. Comparison of thyroid-stimulating hormone (TSH) and free thyroxine (fT4) concentration levels in overweight and 
obese children
Variable
Overweight (n = 472) Obesity (n = 489)
Mean Median SD Mean Median SD
TSH [mU/L] 2.43 2.19 1.25 2.54 2.27 1.40
fT4 [pmol/L] 15.34 15.29 2.9 14.92 14.82 2.21
SD — standard deviation
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The analysis of anthropometric parameters revealed 
positive correlations between TSH concentration and 
both WHR (R = 0.114, p < 0.005) and WHtR (R = 0.095, 
p = 0.003) values for the entire study group (Fig. 1). 
The interpretation of the carbohydrate metabo-
lism results revealed a positive correlation between 
TSH concentration and fasting glucose concentration 
(R = 0.091, p = 0.005) and one-hour glucose concentra-
tion (R = 0.151, p < 0.005), fasting insulin concentration 
(R = 0.172, p < 0.005), one-hour insulin concentration 
(R = 0.193, p < 0.005) and two-hour insulin concentra-
tion (R = 0.145, p < 0.005) (Fig. 2). There was, however, 
a negative correlation between fT4 concentration and 
fasting glucose concentration (R = –0.109, p = 0.001) 
and two-hour glucose concentration (R = –0.079, 
p = 0.015), fasting insulin concentration (R = –0.259, 
p < 0.005), one-hour insulin concentration (R = –0.122, 
p < 0.005) and two-hour insulin concentration 
(R = –0.114, p = 0.001).
In the lipid profile analysis a positive correlation was 
noted between TSH concentration and total cholesterol 
(R = 0.142, p < 0.005), LDL cholesterol (R = 0.251, 
p < 0.005), and triglycerides (R = 0.107, p = 0.001), and 
a negative correlation between fT4 concentrations and 
those of total cholesterol (R = –0.085, p = 0.008) and 
LDL-cholesterol (R = –0.167, p < 0.005).
At the next stage the patients were divided into three 
groups based on their TSH concentrations: < 2.50 mU/L 
(n = 579); 2.50–4.50 mU/L (n = 319); > 4.50 mU/L 
(n = 63).
Teenagers with TSH concentrations < 2.50  mU/L 
(n = 579) exhibited statistically significantly lower 
WHR (p = 0.03), WHtR (p = 0.007), lower fasting glu-
cose concentration (p = 0.008) and one-hour glucose 
concentration (p = 0.001), lower fasting insulin con-
centration (p = 0.001) and one-hour insulin concentra-
tion (p < 0.005) and two-hour insulin concentration 
(p = 0.005), as well as lower concentrations of total 
cholesterol (p = 0.001), LDL cholesterol (p < 0.005), 
and triglycerides (p = 0.021) than the other two groups 
(Fig. 3, 4).
Metabolic syndrome was diagnosed in 70 (7.5%) 
patients, 582 (60%) teenagers had BMI between 25 and 
30 years old, and 119 (12.4%) patients had BMI > 30.
Thirty-one (3.2%) patients from the entire group had 
elevated fasting blood glucose level; however, none was 
diagnosed with diabetes mellitus. Eleven (1.17%) patients 
had triglycerides >150 mg/dL, and 184 (19.1%) teenag-
ers had HDL-cholesterol level < 40 mg/dL. 252 (26.2%) 
patients had blood pressure above 130/85 mm Hg.
Discussion
Numerous scientific reports identify a correlation 
between obesity and increased occurrence of overt or 
sub-clinical hypothyroidism [15]. It is commonly known 
that excessive adipose tissue may contribute to disor-
ders of the pituitary–thyroid axis functioning and, as 
a consequence, cause thyroid function disorders. Due 
to the multi-directional action of thyroid hormones, this 
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Figure 1. Waist-to-hip ratio (WHR) according to thyroid-stimulating hormone (TSH) concentration
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may exert an indirect negative impact on the function-
ing of multiple organs and systems [16]. 
Numerous publications have attempted to compare 
TSH concentrations between obese children and those 
with normal body mass, demonstrating a statistically 
significant increase in TSH concentrations in children 
with excessive body mass [7, 8]. Some researchers have 
also demonstrated significantly higher free thyroxine 
(fT4) concentrations in obese children versus those with 
normal body mass. They attributed this fact to a higher 
conversion of thyroxine (fT4) to free triiodothyronine 
(fT3) caused by increased deiodinase activity, as a com-
pensation mechanism that increases energy consump-
tion in cases of excess adipose tissue accumulation. 
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Figure 2. Glucose level according to thyroid-stimulating hormone (TSH) level
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Figure 3. Glucose level at the baseline according to thyroid-stimulating hormone (TSH) levels
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However, these hypotheses were not supported by 
other studies [9, 10].
Our study reported no differences in TSH con-
centrations between overweight and obese children. 
However, statistically significant lower free thyroxine 
concentrations were observed in obese children versus 
overweight children.
The next stage of the study was to demonstrate 
the association between TSH and fT4 concentrations, 
and anthropometric parameters (WHR, WHtR, BMI), 
glucose and insulin concentrations, and lipid profile.
Polish researchers have attempted a retrospective 
analysis of data acquired from 110 obese children, which 
were compared against test results from 38 healthy 
non-obese children aged 5 to 18 years. A positive cor-
relation between TSH concentration and both BMI and 
WHR was identified [4].
Tiller et al. demonstrated a strong positive correla-
tion between TSH concentration and waist circumfer-
ence, and WHR [17], on a large group of the German 
population, which is in line with our observations. 
Interesting data is provided by analysing a paper 
by Turkish researchers, who demonstrated on a group 
of 111 obese teenagers and 42 healthy peers that the 
obese patients had higher TSH concentrations, which 
positively correlated with total cholesterol, LDL choles-
terol, triglycerides, and fasting insulin concentrations 
[18]. Similar conclusions were drawn by Norwegian 
researchers, who, having examined the medical records 
of 30,000 patients without a coexisting thyroid disease, 
demonstrated that along with an increase in TSH 
concentration (still within the generally accepted refer-
ence range for the population) there were statistically 
significant increases in total cholesterol concentration, 
LDL cholesterol, triglycerides, and a reduction in HDL 
cholesterol concentration [19].
On the other hand, Radetti et al. in their retrospec-
tive study on 833 adolescents showed that elevated TSH 
levels in obese teenagers could negatively influence the 
cardiac status of the patients because of higher total 
cholesterol level as well as higher blood pressure [20]. 
Therefore, most researchers agree that the higher 
the thyrotropin concentration, the more disrupted the 
carbohydrate metabolism is (higher fasting glucose 
and two-hour glucose concentrations), which is ac-
companied by an increase of cardiovascular risk due 
to increased concentrations of total cholesterol, LDL 
cholesterol, and triglycerides. The question therefore 
arises: what TSH concentration can be considered safe 
in terms of metabolic consequences and well-tolerated 
in paediatric patients? Should we modify the generally 
accepted interpretation of TSH reference values or de-
fine risk thresholds for the development of metabolic 
complications? 
The next stage of our study was the division of 
patients according to TSH concentrations. In the 
subsequent tests it was noted that the teenagers 
from the group with the lowest TSH concentrations 
(≤ 2.50 mIU/L) were characterised by the lowest (favour-
able) waist-to-hip ratio (WHR), lowest concentration 
levels of total cholesterol, LDL cholesterol, triglycerides, 
and significantly lower fasting glucose and insulin lev-
Figure 4. Insulin levels according to thyroid-stimulating hormone (TSH) levels
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els, as well as a lower oral glucose tolerance test results 
than patients with TSH concentrations in the upper half 
of the reference range and with TSH > 4.50 mIU/L. Simi-
lar observations were made by German researchers, 
who examined 1333 people with normal TSH concentra-
tions and demonstrated an increased risk of developing 
metabolic syndrome in people with TSH concentrations 
in the upper half of the reference range, compared to 
patients with TSH concentrations < 2.50 mIU/L, which 
was indicated by a higher waist-to-hip ratio (WHR) and 
higher triglyceride concentration [21].   
Similar conclusions were also drawn by Souza 
et al., who demonstrated in a group of 199 obese or 
overweight teenagers that TSH concentration was 
positively correlated with the HOMA insulin resistance 
index, total cholesterol concentration, and triglyceride 
concentration [22].
Therefore, a TSH concentration in the lower half 
of the reference range for the general population (< 
2.50 mIU/L) seems to have a protective impact on the 
organism by reducing cardiovascular risk [20, 23, 24].
The arising questions are whether pharmacology 
is the only way to lower the TSH level and at what 
stage starting the treatment with L-thyroxine seems 
to be inevitable. 
According to Wolters et al. as well as Reinehr et al., 
substantial weight loss can be associated with lowering 
TSH levels in obese children and adolescents [25, 26]. 
However, most scientists agree that the treatment with 
L-thyroxine seems to be advisable when TSH level is 
above 10 mIU/L [27], which we also did in the case of 
three patients in our study.
It is also worth mentioning the article of 
Witkowska-Sędek et al., in which the authors claim 
that the treatment of subclinical hypothyroiditis and 
in such a way, lowering the level of TSH, can make it 
harder for obese teenagers to maintain reduced body 
weight [28].
Diagnostic criteria of metabolic syndrome in teenag-
ers between 10–16 years old are still being discussed, 
and it is hard to find valuable data about the incidence 
of metabolic syndrome in this age group [29]. In our 
study, metabolic syndrome was diagnosed in 7.5% of 
all analysed patients but in 20% of teenagers with BMI 
above 30 kg/m2. 
The aim of PoZdro! — National Program for the 
Prevention of Diabetes and Civilisation-related Dis-
eases — is to raise public awareness of healthy lifestyle 
expressed through a healthy, balanced diet and regular 
physical exercise, which should result in a reduction of 
body weight in overweight or obese teenagers taking 
part in the two-year program. 
We hope that re-testing thyroid hormonal param-
eters after the completion of this study, which should 
result in a reduction of our patients’ body mass, will 
provide further interesting conclusions regarding the 
association of TSH and fT4 concentrations and the risk 
of developing metabolic syndrome in children and 
adolescents.
Conclusions
TSH concentration in the upper half of the current 
reference range (> 2.50 mIU/L) is associated with 
an increased risk of lipid and carbohydrate metabolism 
disorders and therefore increased chances of develop-
ing metabolic syndrome. It seems advisable to regularly 
monitor thyroid function in overweight and obese 
paediatric patients.
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